Literature DB >> 17389264

Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension.

Joanna Burns1, Mohan U Sivananthan, Stephen G Ball, Alan F Mackintosh, David A S G Mary, John P Greenwood.   

Abstract

BACKGROUND: Sympathetic activation has been implicated in the development of left ventricular hypertrophy (LVH). However, the relationship between sympathetic activation and LV mass (LVM) has not been clearly defined across a range of arterial pressure measurements. The present study was planned to determine that relationship, using cardiac magnetic resonance imaging to accurately quantify LVM, in hypertensive patients with and without LVH and in normal subjects. METHODS AND
RESULTS: Twenty-four patients with uncomplicated and untreated essential hypertension (LVH[-]) were compared with 25 patients with essential hypertension and left ventricular hypertrophy (LVH[+]) and 24 normal control subjects. Resting muscle sympathetic nerve activity was quantified as multiunit bursts and single units. Cardiac magnetic resonance imaging-determined LVM was indexed to body surface area (LVM index); in the LVH[-] group, LVM index was 67+/-2.1 g/m2, a value between those of the LVH[+] (91+/-3.4 g/m2) and normal control (57+/-2.2 g/m2) groups, respectively. The sympathetic activity in the LVH[-] group (53+/-1.3 bursts per 100 cardiac beats and 63+/-1.6 impulses per 100 cardiac beats) was between (at least P<0.001) those of the LVH[+] (66+/-1.7 bursts per 100 cardiac beats and 77+/-2.2 impulses per 100 cardiac beats) and normal control (39+/-3.0 bursts per 100 cardiac beats and 45+/-3.4 impulses per 100 cardiac beats) groups. Significant positive correlation existed between sympathetic activity and LVM index in the LVH[-] and LVH[+] groups (at least r=0.76, P<0.0001) but not in the normal control group. However, no consistent relationship existed between arterial blood pressure and sympathetic activity or LVM index.
CONCLUSIONS: These findings further support the hypothesis that central sympathetic activation is associated with the development of LVH in human hypertension.

Entities:  

Mesh:

Year:  2007        PMID: 17389264      PMCID: PMC3925820          DOI: 10.1161/CIRCULATIONAHA.106.668863

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  45 in total

Review 1.  Sympathetic activation in the pathogenesis of hypertension and progression of organ damage.

Authors:  G Mancia; G Grassi; C Giannattasio; G Seravalle
Journal:  Hypertension       Date:  1999-10       Impact factor: 10.190

2.  Steady-state free precession magnetic resonance imaging of the heart: comparison with segmented k-space gradient-echo imaging.

Authors:  S Plein; T N Bloomer; J P Ridgway; T R Jones; G J Bainbridge; M U Sivananthan
Journal:  J Magn Reson Imaging       Date:  2001-09       Impact factor: 4.813

Review 3.  Assessment of left ventricular mass by cardiovascular magnetic resonance.

Authors:  Saul G Myerson; Nicholas G Bellenger; Dudley J Pennell
Journal:  Hypertension       Date:  2002-03-01       Impact factor: 10.190

4.  Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences.

Authors:  Khaled Alfakih; Sven Plein; Holger Thiele; Tim Jones; John P Ridgway; Mohan U Sivananthan
Journal:  J Magn Reson Imaging       Date:  2003-03       Impact factor: 4.813

5.  Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension.

Authors:  P Verdecchia; G Reboldi; G Schillaci; C Borgioni; A Ciucci; M P Telera; F Santeusanio; C Porcellati; P Brunetti
Journal:  Circulation       Date:  1999-10-26       Impact factor: 29.690

6.  Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging.

Authors:  C H Lorenz; E S Walker; V L Morgan; S S Klein; T P Graham
Journal:  J Cardiovasc Magn Reson       Date:  1999       Impact factor: 5.364

7.  Performance of QRS detection for cardiac magnetic resonance imaging with a novel vectorcardiographic triggering method.

Authors:  J M Chia; S E Fischer; S A Wickline; C H Lorenz
Journal:  J Magn Reson Imaging       Date:  2000-11       Impact factor: 4.813

8.  TrueFISP: assessment of accuracy for measurement of left ventricular mass in an animal model.

Authors:  David S Fieno; Wyatt C Jaffe; Orlando P Simonetti; Robert M Judd; J Paul Finn
Journal:  J Magn Reson Imaging       Date:  2002-05       Impact factor: 4.813

Review 9.  The sympathetic system and hypertension.

Authors:  M Esler
Journal:  Am J Hypertens       Date:  2000-06       Impact factor: 2.689

10.  Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive.

Authors:  J P Greenwood; E M Scott; J B Stoker; D A Mary
Journal:  J Am Coll Cardiol       Date:  2001-11-15       Impact factor: 24.094

View more
  35 in total

1.  Baroreflex activation as a novel therapeutic strategy for diastolic heart failure.

Authors:  Mathias C Brandt; Navid Madershahian; Ralf Velden; Uta C Hoppe
Journal:  Clin Res Cardiol       Date:  2010-11-06       Impact factor: 5.460

2.  Divergence of hypertrophic growth and fetal gene profile: the influence of beta-blockers.

Authors:  X-J Du
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

Review 3.  Renal denervation for arrhythmias: hope or hype?

Authors:  Jonathan S Steinberg; Evgeny Pokushalov; Suneet Mittal
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

Review 4.  Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness.

Authors:  Dan Li; David J Paterson
Journal:  J Physiol       Date:  2016-05-05       Impact factor: 5.182

Review 5.  New approaches to quantifying sympathetic nerve activity.

Authors:  Sandra L Burke; Elisabeth Lambert; Geoffrey A Head
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

6.  Renal denervation in the treatment of resistant arterial hypertension.

Authors:  Thomas Lambert; Wilhelm Schützenberger; Clemens Steinwender
Journal:  Wien Med Wochenschr       Date:  2014-11-14

7.  Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease.

Authors:  Guido Grassi; Gino Seravalle; Lorenzo Ghiadoni; Giovanni Tripepi; Rosa Maria Bruno; Giuseppe Mancia; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-22       Impact factor: 8.237

Review 8.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

9.  Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling.

Authors:  Shuli Wang; Hongjie Hu; Minjie Lu; Arlene Sirajuddin; Jinghui Li; Jing An; Xiuyu Chen; Gang Yin; Tian Lan; Linlin Dai; Yan Zhang; Xiaorong Yin; Lei Song; Aimin Dang; Peter Kellman; Andrew E Arai; Shihua Zhao
Journal:  Eur Radiol       Date:  2017-04-24       Impact factor: 5.315

Review 10.  Neural and nonneural mechanisms for sex differences in elderly hypertension: can exercise training help?

Authors:  Qi Fu; Wanpen Vongpatanasin; Benjamin D Levine
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.